QLYS:NASDAQQualys, Inc. Analysis
Data as of 2026-04-27 - not real-time
$84.34
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Qualys is trading at $84.34, well below its 20‑day SMA of 84.86, 50‑day SMA of 91.71 and the 200‑day SMA of 124, indicating a sustained downtrend despite a bullish MACD histogram (+0.87) and a neutral RSI of 44. The stock’s PE of 15.5 is dramatically lower than the industry average of 38, and the DCF‑derived fair value of $162.6 suggests a potential upside of nearly 50%. However, recent analyst sentiment has soured, with TD Cowen and RBC Capital slashing price targets to $90 and $85 respectively, citing competitive pressure from emerging AI‑driven cybersecurity tools and a looming earnings report. The company’s fundamentals remain strong—10% revenue growth, 82% gross margin, 38% ROE, and a solid cash position of $445 M versus $52 M debt—yet high 30‑day volatility (≈60%) and a historic max drawdown of 50% amplify short‑term risk. In summary, the stock appears fundamentally undervalued with significant upside, but near‑term uncertainty from analyst downgrades and sector disruption warrants caution.
The technical picture shows price hovering near the $74.5 support level, while the resistance at $92.0 remains intact. Stable volume and a low beta (0.57) suggest limited market‑wide swings, but the sector’s rapid innovation cycle and regulatory scrutiny elevate medium‑term risk. Investors should monitor the Q1 2026 earnings release and any further guidance on competitive positioning before committing larger positions.
The technical picture shows price hovering near the $74.5 support level, while the resistance at $92.0 remains intact. Stable volume and a low beta (0.57) suggest limited market‑wide swings, but the sector’s rapid innovation cycle and regulatory scrutiny elevate medium‑term risk. Investors should monitor the Q1 2026 earnings release and any further guidance on competitive positioning before committing larger positions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Analyst price‑target cuts to $85‑$90
- Upcoming Q1 earnings volatility
- Price near technical support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong operating margins and cash flow
- Potential upside versus DCF fair value
- Competitive pressure from AI‑driven security solutions
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High ROE and consistent revenue growth
- Undervalued valuation metrics relative to peers
- Long‑term demand for cloud‑based security and compliance platforms
Key Metrics & Analysis
Financial Health
Revenue Growth10.10%
Profit Margin29.64%
P/E Ratio15.5
ROE38.20%
ROA13.41%
Debt/Equity9.31
P/B Ratio5.4
Op. Cash Flow$309.4M
Free Cash Flow$259.1M
Industry P/E38.1
Technical Analysis
TrendBearish
RSI44.4
Support$74.51
Resistance$92.02
MA 20$84.86
MA 50$91.71
MA 200$124.00
MACDBullish
VolumeStable
Fear & Greed Index88.02
Valuation
Fair Value$162.56
Target Price$126.23
Upside/Downside49.67%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.57
Volatility60.67%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.